GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Luxbright AB (OSTO:LXB) » Definitions » ROCE %

Luxbright AB (OSTO:LXB) ROCE % : -66.28% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Luxbright AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Luxbright AB's annualized ROCE % for the quarter that ended in Jun. 2023 was -66.28%.


Luxbright AB ROCE % Historical Data

The historical data trend for Luxbright AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luxbright AB ROCE % Chart

Luxbright AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
-128.96 -96.21 -46.39 -57.63 -84.70

Luxbright AB Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -49.26 -68.90 -68.37 -62.78 -66.28

Luxbright AB ROCE % Calculation

Luxbright AB's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-21.089/( ( (23.994 - 2.266) + (31.192 - 3.122) )/ 2 )
=-21.089/( (21.728+28.07)/ 2 )
=-21.089/24.899
=-84.70 %

Luxbright AB's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=-24.838/( ( (31.192 - 3.122) + (48.53 - 1.654) )/ 2 )
=-24.838/( ( 28.07 + 46.876 )/ 2 )
=-24.838/37.473
=-66.28 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luxbright AB  (OSTO:LXB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Luxbright AB ROCE % Related Terms

Thank you for viewing the detailed overview of Luxbright AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Luxbright AB (OSTO:LXB) Business Description

Traded in Other Exchanges
Address
Arvid Wallgrens backe 20, Gothenburg, SWE, 41346
Luxbright AB is a technology company focusing on developing and commercializing a new generation of X-ray tubes. The company offers innovative X-ray tubes, generators, and future X-ray systems to international system suppliers in order to improve and protect lives by enabling higher resolution X-ray images. The X-ray tubes are a powerful, stable, and cost-effective alternative to conventional X-ray tubes.

Luxbright AB (OSTO:LXB) Headlines

No Headlines